ArticleTherapeutic advances in gastroenterology2026

The efficacy and safety of etrasimod as a first-line advanced therapy for ulcerative colitis: prespecified and post hoc subgroup data from the ELEVATE UC clinical program.

David T Rubin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.